Professional Documents
Culture Documents
CW3
CW3
Furthermore, post-
marketing surveillance
often reveals
unforeseen safety
issues with newly
approved drugs,
prompting regulatory
agencies to reassess
risk-benefit profiles
and issue warnings or
recalls. This
phenomenon
underscores the
inherent limitations of
pre-market testing and
highlights the
importance of vigilant
pharmacovigilance in
safeguarding public
health.
In addition, the
modern medical
system faces
challenges in managing
chronic diseases, such
as autoimmune
disorders and
metabolic syndromes.
While acute conditions
may garner immediate
attention and
resources, chronic
illnesses require long-
term care strategies
that address
multifaceted factors,
including lifestyle
modifications,
psychosocial support,
and holistic wellness
approaches.
Moreover, the
emergence of drug-
resistant pathogens
poses a formidable
threat to modern
medicine's arsenal of
antimicrobial agents.
Overreliance on
antibiotics, coupled
with suboptimal
infection control
practices, has fueled
the proliferation of
resistant strains,
rendering once-
effective treatments
obsolete and
necessitating the
development of novel
therapeutics.
In conclusion, the
modern medical
system embodies a
double-edged sword,
offering unparalleled
advancements
alongside inherent
limitations. By critically
assessing its strengths
and weaknesses,
stakeholders can foster
a culture of continuous
improvement, striving
to enhance patient-
centered care,
promote health equity,
and embrace a holistic
vision of wellness that
transcends biomedical
paradigms. Only
through collective
efforts and
interdisciplinary
collaboration can we
navigate the
complexities of modern
medicine and realize its
full potential in
advancing human
health and well-being.